WASHINGTON – U.S. FDA commissioner Scott Gottlieb had some pointed words for drugmakers regarding data integrity at a Food and Drug Law Institute (FDLI) meeting in the nation's capital, while Bill Maisel, the acting director of the agency's device center, had better news for device makers on regulatory harmonization efforts.